SUMMARY The effect of pregnancy on seizure frequency was monitored prospectively in 136 pregnancies of 122 epileptic women. Pregnancy did not influence the seizure frequency in 68 pregnancies (50%). In 50 pregnancies (37%) the number of seizures increased during pregnancy or puerperium. The seizure frequency decreased in 18 pregnancies (13%). In 34 out of 50 pregnancies (68%) the increase was associated with non-compliance with the drug regimen or sleep deprivation. In seven out of 18 pregnancies (39%) improvement was related to correction of non-compliance or sleep deprivation during the pregestational nine months. Insufficiently low plasma concentrations of antiepileptic drugs were found in 47% of the women with uncontrolled epilepsy during pregnancy. The course of epilepsy during pregnancy is primarily influenced by non-compliance, sleep deprivation during pregnancy, and inadequate therapy before and during pregnancy. With good medical attention pregnancy itself seems to have only a minimal influence on the course of epilepsy.
Improvements in the drug therapy of epilepsy have led to a growing number of well controlled epileptic women in childbearing age. It is therefore not surprising that the influence of pregnancy on the course of epilepsy has received renewed interest. According to a recent review, the seizure frequency improved in 23% and deteriorated in another 24% of 2165 pregnancies.' A number of variables may influence the seizure frequency. These include hormonal and metabolic factors, respiratory changes, psychological problems, non-compliance with the prescribed drugs regimen, changes in pharmocokinetics of antiepileptic drugs, and a modification of seizure propensity during pregnancy.' Preliminary studies suggested that non-compliance, seizure provocation, and a decrease in the plasma concentration of antiepileptic drugs may be primarily involved in the regulation of seizure frequency during pregnancy.23 Changes in seizure propensity can be studied directly in pregnant women not receiving antiepileptic drugs. The purpose of this prospective two-centre study of 136 pregnancies was to investigate changes in seizure frequency during pregnancy and to analyse clinical and pharmacological factors associated with a seizure relapse in the individual patient.
Patients and Methods
A total of 136 pregnancies of 122 epileptic women were followed prospectively from 1977 to 1981 in West-Berlin, Germany and Milan, Italy. Pregnant women were excluded from the study if they had a total of less than three verified epileptic seizures, the data on the seizure frequency were incomplete or the pregnancy was ended by abortion. The patients were referred to the Epilepsy Clinic in Milan and Berlin from departments of gynaecology and neurology and gynaecologists and neurologists for pregnancy planning and during early pregnancy.23 The project was made known to them by regular distribution of information in letters and reprints. The patients were evaluated neurologically and usually seen at monthly intervals, when the history of seizures was recorded. At each visit the patients were examined for clinical drug toxicity. Special emphasis was given to the history of the clinical factors possibly associated with an increase in seizure frequency or a relapse of seizures. The patients were asked specifically Schmidt, Canger, Avanzini, Battino, Cusi, Beck-Mannagetta, Koch, Rating, Janz whether they had taken the daily dose regularly in the days before each individual seizure. Non-compliance was assumed only when the patient admitted to it. Furthermore, information was sought on seizure provocation by sleep deprivation, and consumption of ethanol, or both. Sleep deprivation was defined as a delay of more than 2 hours from the usual working day onset of sleep for the individual patient. Sleep deprivation was assumed to be a predisposing factor only in patients with a previous history of seizure provocation through sleep deprivation. At each visit the plasma concentration of phenytoin, phenobarbitone, carbamazepine, ethosuximide and valproic acid was measured in duplicate by enzyme immunoassay as described previously.4 For quality control the Jaboratories joined the European Quality Control Scheme organised by Prof A. Richens.5 One drug treatment was administered in 86 pregnancies (63%) with carbamazepine (n = 12), primidone (n = 22), phenobarbitone (n-= 20), phenytoin (n = 23), valproic acid (n = 4), ethosuximide (n = 3) or clobazam (n = 2). Two Decreased seizure frequency The pregnancy seemed to have a beneficial effect on seizure frequency in 18 pregnancies. The number of seizures decreased by 50% (23%-70%) in seven patients, and 11 patients became completely controlled during pregnancy. In seven women noncompliance or sleep deprivation was associated with seizures in the pregestational nine months, while the women remained free of seizures during pregnancy. In four out of the remaining 11 pregnancies the plasma concentration was increased or a new drug In 53 pregnancies the number of seizures was compared from nine months before to 12 months following the pregnancy. In 34 pregnancies (64%) a similar number of seizures or absence of seizures was recorded in the pregestational nine months and during months 4 to 12 following the delivery. In 17 pregnancies the seizures returned to the pregestational frequency after an increase or a decrease during pregnancy. In 19 pregnancies the number of seizures was lower (n = 17) during the pregestational period, and only rarely higher (n = 2).
The course of epilepsy was studied during 23 pregnancies without antiepileptic drug therapy. There was no change in seizure frequency in 13 out of 23 pregnancies (57%). In eight pregnancies (35%) the number of seizures increased. Sleep deprivation was responsible in six of eight pregnancies. In two pregnancies (9%) the number of seizures improved. When compared to the changes in seizure frequency in women receiving drug treatment there was no significant difference.
The first antiepileptic drug plasma concentration obtained during pregnancy was either below 10 ,ug/ml phenytoin, or 25 ug/ml phenobarbitone 4 Ag/ml carbamazepine or 50 ,ug/ml ethosuximide and valproic acid in 63% of all 98 pregnancies despite uncontrolled seizure before (n= 75) or during (n = 23) pregnancy. The highest plasma concentrations of antiepileptic drugs during pregrancy were still below this range in 47% of the patients with uncontrolled epilepsy.
Discussion
Pregnancy had either no or a beneficial influence on the seizure frequency in nearly two-thirds of all pregnancies. In 50 pregnancies (37%) the number of seizures increased during pregnancy. This overall result is similar to that of prospective studies in Finland6 and Canada,7 and retrospective reports.8-'0 A discussion of the factors responsible for a change in the course of epilepsy must consider the random fluctuations of seizure frequency observed during a 18 months period in any patient regardless of pregnancy, and try to establish factors specific for the pregnant epileptic women which could possibly influence the course of epilepsy. At the onset of pregnancy the seizures were uncontrolled in 75 pregnancies (55%) suggesting less than optimal drug treatment prior to the pregnancy if one accepts that complete seizure control can be achieved in 70-80% of the patients with adequate drug therapy." This is supported by the finding that 63% of these women were treated with inadequately low plasma concentrations of antiepileptic drugs. The highest plasma concentrations of antiepileptic drugs during pregnancy were still below the accepted therapeutic range in 47% of the pregnant women with uncontrolled epilepsy.
One mechanism for a reduction of the seizure frequency during pregnancy was the improvement of inadequate therapy prior to the pregnancy or the correction of non-compliance and sleep deprivation in 11 of 18 pregnancies (61 %). Change of seizure frequency in pregnant epileptic women cian is unaware of her drug treatment or someone has simply forgotten to give her the drug in the hospital. Additional sleep deprivation which may occur throughout during the pregnancy, is characteristically associated with a relapse of seizure during breast feeding in the puerperium. Care should be taken that the mother has her regular hours of sleep, possibly through the help of the husband or a relative who takes care of the child at night. In 16 out of the 50 pregnancies with increased seizure frequency non-compliance or sleep deprivation were not involved according to the patient's history. In nine of these pregnancies the drug treatment was not sufficient to increase the steady-state plasma concentration above those during pregestational period where the patients were uncontrolled. In one pregnancy the seizure frequency increased despite higher plasma concentration during pregnancy. Consequently, the increase in seizure frequency remains unexplained in six pregnancies and may entirely reflect the spontaneous course of chronic epilepsies during a period of 18 months regardless of pregnancy. Furthermore, sleep deprivation was responsible for the increased seizure frequency in six of eight pregnancies of women not taking antiepileptic drugs indicating that it is a major factor for the deterioration of untreated epilepsies. In this series clinical data other than those related to noncompliance and sleep deprivation were not helpful to predict the individual's course of epilepsy during pregnancy. We could not confirm the value of the pre-pregnancy frequency of generalised tonic-clonic seizures, the duration of epilepsy, and the course of epilepsy in previous pregnancies as suggested by Remillard et al.' This report is in agreement with the large Finnish series of Bardy6 who likewise found no clinical factors which predict the increase in the number of seizures. The clinical implication of our data for the management of the pregnant epileptic woman suggest that a renewed effect should be made to completely control the epilepsy with the help of adequate drug therapy when pregnancy is planned. Specific risks include the discontinuation or reduction of drug therapy especially during early pregnancy, deficient drug delivery in the obstetric department, and seizure provocation through sleep deprivation during pregnancy and breast feeding.
In conclusion then, pregnancy itself does seem to have only a minimal effect on the course of epilepsy, if at all. In the few patients with an unexplained increase of seizure frequency the influence of other factors (e.g. hormonal, random fluctuations of seizure frequency) remains to be evaluated.
